Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a randomized, blank-controlled study in adults with household contact exposure to individuals with SARS-CoV-2 infection. All subjects in the study will be household contacts with close exposure to the first household member known to be newly infected with SARS-CoV-2. Subjects in each cohort will be randomly assigned to the Chinese herbal medicine treatment group or blank control group in a 4:1 ratio, followed by 1 week of the treatment period and 2 weeks of follow-up.
Epistemonikos ID: 8bd1424db987b9f65a97f7e9ca810155c70342f0
First added on: Mar 09, 2022